Share Twitter LinkedIn Facebook Email Dr. Irene Ghobrial and Dr. Karen Winkfield discuss the markers surrounding the disease and those people most at risk for developing it
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read
